Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence
![Appraising ultra orphan drugs cover page](https://www.ohe.org/wp-content/uploads/2018/03/Appraising-ultra-orphan-drugs-cover-page_0.jpg)
Original research is at the heart of what we do. For more than 60 years, our experts have published across a wide range of topics from the fundamentals of health economics itself to the challenges facing health care in the UK and internationally.